Drug Profile
Clotrimazole enema - AesRx
Alternative Names: Aes-210; CorrectaLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Childrens Hospital Boston
- Developer AesRx; Childrens Hospital Boston
- Class Antifungals; Chlorobenzenes; Imidazoles; Small molecules
- Mechanism of Action 14-alpha demethylase inhibitors; Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pouchitis
Most Recent Events
- 25 Jun 2015 No recent reports of development identified - Phase-II for Pouchitis (In children) in USA (Rectal)
- 25 Jun 2015 No recent reports of development identified - Phase-II for Pouchitis in USA (Rectal)
- 09 Jul 2014 AesRx has been acquired by Baxter International